Skip to main content

AMGEN INC

For the period ended Mar 31, 2024. Filed May 3, 2024.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Mar 31, 2024 · Filed May 3, 2024

AMGN$465.230.0%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

CONDENSED CONSOLIDATED STATEMENTS OF (LOSS) INCOME

Three months endedMarch 31,
20242023
Revenues:
Product sales$7,118$5,846
Other revenues329259
Total revenues7,4476,105
Operating expenses:
Cost of sales3,2001,720
Research and development1,3431,058
Selling, general and administrative1,8081,258
Other105148
Total operating expenses6,4564,184
Operating income9911,921
Other income (expense):
Interest expense, net(824)(543)
Other (expense) income, net(235)2,064
(Loss) income before income taxes(68)3,442
Provision for income taxes45601
Net (loss) income$(113)$2,841
(Loss) earnings per share:
Basic$(0.21)$5.32
Diluted$(0.21)$5.28
Shares used in calculation of (loss) earnings per share:
Basic536534
Diluted536538
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.